Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lara Bapir, Simon Erridge, Martha Nicholas, Manaswini Pillai, Nishaanth Dalavaye, Carl Holvey, Ross Coomber, Jonathan Hoare, Shaheen Khan, Mark W Weatherall, James J Rucker, Michael Platt & Mikael H Sodergren. (2023) Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study. Expert Review of Neurotherapeutics 23:3, pages 281-295.
Read now
Read now
Ryan S. D’Souza, Brendan Langford, Rachel E. Wilson, Yeng F. Her, Justin Schappell, Jennifer S. Eller, Timothy C. Evans & Jonathan M. Hagedorn. (2022) The state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain. Expert Opinion on Pharmacotherapy 23:7, pages 775-789.
Read now
Read now
José María Prieto González & Carlos Vila Silván. (2021) Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials. Expert Review of Neurotherapeutics 21:7, pages 755-778.
Read now
Read now
Articles from other publishers (30)
Satish Jankie, Keshav Sewdass, William Smith, Candy Naraynsingh, Jenelle Johnson, Niall Farnon, Kavita Mahadeo & Shastri Motilal. (2023) A cross-sectional survey of prospective healthcare professionals' knowledge, attitudes and perceptions of medical Cannabis. Exploratory Research in Clinical and Social Pharmacy 10, pages 100275.
Crossref
Crossref
Elise A Schubert, Masego T Johnstone, Melissa J Benson, Johannes C Alffenaar & Nial J Wheate. (2022) Medicinal cannabis for Australian patients with chronic refractory pain including arthritis. British Journal of Pain 17:2, pages 206-217.
Crossref
Crossref
Toni C. Spinella, Jeremy Bartholomeusz, Sherry H. Stewart & Sean P. Barrett. (2023) Perceptions about THC and CBD effects among adults with and without prior cannabis experience. Addictive Behaviors 137, pages 107508.
Crossref
Crossref
ANTON V. SYROESHKIN, DARIA A. GALKINA, DAIAANA D. OGOTOEVA, OLGA V. LEVITSKAYA, MARIYA A. MOROZOVA & TATIANA V. PLETENEVA. (2023) COMPARISON OF BIOPHARMACEUTICAL PARAMETERS OF CANNABINOIDS AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS BY QSAR METHOD. International Journal of Applied Pharmaceutics, pages 269-273.
Crossref
Crossref
Carley Marie Huffstetler, Brigitte Cochran, Camilla Ann May, Nicholas Maykut, Claudia Rose Silver, Claudia Cedeno, Ezabelle Franck, Alexis Cox & Debra Ann Fadool. (2023) Single cannabidiol administration affects anxiety-, obsessive compulsive-, object memory-, and attention-like behaviors in mice in a sex and concentration dependent manner. Pharmacology Biochemistry and Behavior 222, pages 173498.
Crossref
Crossref
Alistair W. Vickery, Sebastian Roth, Tracie Ernenwein, Jessica Kennedy & Patrizia Washer. (2022) A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years. PLOS ONE 17:11, pages e0272241.
Crossref
Crossref
P. Silva Santos Ribeiro, Hanneke L. D. M. Willemen & Niels Eijkelkamp. (2022) Mitochondria and sensory processing in inflammatory and neuropathic pain. Frontiers in Pain Research 3.
Crossref
Crossref
Diana E. Sepulveda, Kent E. Vrana, Nicholas M. Graziane & Wesley M. Raup-Konsavage. (2022) Combinations of Cannabidiol and Δ9-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain. Biomedicines 10:10, pages 2548.
Crossref
Crossref
Sophie Pautex, Federica Bianchi, Youssef Daali, Marc Augsburger, Christian de Saussure, James Wampfler, François Curtin, Jules Desmeules & Barbara Broers. (2022) Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Kathleen Louis-Gray, Srinivasan Tupal & Louis S. Premkumar. (2022) TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids. International Journal of Molecular Sciences 23:17, pages 10016.
Crossref
Crossref
Ankit Uniyal, Akhilesh, Aaina Singh Rathore, Priyanka Kumari Keshri, Surya Pratap Singh, Sanjay Singh & Vinod Tiwari. (2022) Inhibition of pan-Aurora kinase attenuates evoked and ongoing pain in nerve injured rats via regulating KIF17-NR2B mediated signaling. International Immunopharmacology 106, pages 108622.
Crossref
Crossref
Radhika Anand, Pankaj Singh Cham, Veeranjaneyulu Gannedi, Sumit Sharma, Mukesh Kumar, Rohit Singh, Ram A. Vishwakarma & Parvinder Pal Singh. (2022) Stereoselective Synthesis of Nonpsychotic Natural Cannabidiol and Its Unnatural/Terpenyl/Tail-Modified Analogues. The Journal of Organic Chemistry 87:7, pages 4489-4498.
Crossref
Crossref
Clara Schulze-Schiappacasse, Josefina Durán, Rocío Bravo-Jeria, Francisca Verdugo-Paiva, Macarena Morel & Gabriel Rada. (2022) Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence. JCR: Journal of Clinical Rheumatology 28:2, pages e563-e567.
Crossref
Crossref
Helen Senderovich, Hayley Wagman, Dennis Zhang, Danusha Vinoraj & Sarah Waicus. (2022) The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review. Gerontology 68:6, pages 612-624.
Crossref
Crossref
C. Miyabe Shields & Riley D. Kirk. 2022. Revolutionizing the Potential of Hemp and Its Products in Changing the Global Economy. Revolutionizing the Potential of Hemp and Its Products in Changing the Global Economy
97
133
.
Jason Turner, Mehmed Kantardzic & Rachel Vickers-Smith. (2021) Infodemiological Examination of Personal and Commercial Tweets About Cannabidiol: Term and Sentiment Analysis. Journal of Medical Internet Research 23:12, pages e27307.
Crossref
Crossref
Shahriar S. M. Shakil, Matt Gowan, Kerry Hughes, Md. Nur Kabidul Azam & Md. Nasir Ahmed. (2021) A narrative review of the ethnomedicinal usage of Cannabis sativa Linnaeus as traditional phytomedicine by folk medicine practitioners of Bangladesh. Journal of Cannabis Research 3:1.
Crossref
Crossref
Barbara Stella, Francesca Baratta, Carlo Della Pepa, Silvia Arpicco, Daniela Gastaldi & Franco Dosio. (2021) Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain. Drugs 81:13, pages 1513-1557.
Crossref
Crossref
Farah Deeba, Ashish Kumar, Monalisa Mukherjee, Arun K. Sharma & Manju Sharma. (2021) Targeting the endocannabinoid system in diabesity: Fact or fiction?. Drug Discovery Today 26:7, pages 1750-1758.
Crossref
Crossref
Xandy Melissa Rodríguez MesaAndrés Felipe Moreno Vergara, Leonardo Andrés Contreras BolañosNatalia Guevara MorionesAntonio Luis Mejía PiñerosSandra Paola Santander González. (2021) Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases. Cannabis and Cannabinoid Research 6:3, pages 196-210.
Crossref
Crossref
Igor Dykukha, Rolf Malessa, Ute Essner & Michael A Überall. (2021) Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials. Pain Medicine 22:4, pages 861-874.
Crossref
Crossref
Justin E. LaVigne, Ryan Hecksel, Attila Keresztes & John M. Streicher. (2021) Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific Reports 11:1.
Crossref
Crossref
Gabriele Schmidt-Wolf & Peter Cremer-Schaeffer. (2021) 3 Jahre Cannabis als Medizin – Zwischenergebnisse der CannabisbegleiterhebungThree years of cannabis as medicine—preliminary results of the survey accompanying the prescription of medical cannabis in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 64:3, pages 368-377.
Crossref
Crossref
Richard C. Kevin, Rebecca Vogel, Peter Doohan, Maximus Berger, G. Paul Amminger & Iain S. McGregor. (2020)
A validated method for the simultaneous quantification of cannabidiol, Δ
9
‐tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open‐label trial
. Drug Testing and Analysis 13:3, pages 614-627.
Crossref
Crossref
Hanane Zaki & Mohammed Bouachrine. (2021) Can Cannabinoids Suppress the Cytokines Cascade in Patients with Coronavirus Disease COVID-19? A Mini-Review. Coronaviruses 2:2, pages 187-192.
Crossref
Crossref
Jason S. Turner, Mehmed M. Kantardzic & Rachel Vickers-Smith. 2021. Mediterranean Forum – Data Science Conference. Mediterranean Forum – Data Science Conference
139
150
.
Dennis J. Sholler, Marilyn A. Huestis, Benjamin Amendolara, Ryan Vandrey & Ziva D. Cooper. (2020) Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids. Pharmacology Biochemistry and Behavior 199, pages 173059.
Crossref
Crossref
Alistair W. Vickery & Phillip M. Finch. (2020) Cannabis: are there any benefits?. Internal Medicine Journal 50:11, pages 1326-1332.
Crossref
Crossref
Kristy R. Kutanzi, Laura E. Ewing, Charles M. Skinner, Charles M. Quick, Stefanie Kennon-McGill, Mitchell R. McGill, Larry A. Walker, Mahmoud A. ElSohly, Bill J. Gurley & Igor Koturbash. (2020) Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Extract and Methylsulfonylmethane Co-Administration. International Journal of Molecular Sciences 21:20, pages 7808.
Crossref
Crossref
Patrícia Alves, Cristina Amaral, Natércia Teixeira & Georgina Correia-da-Silva. (2020) Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol. Pharmacological Research 157, pages 104822.
Crossref
Crossref